Canadian Consortium on Neurodegeneration in Aging

Canadian Consortium on Neurodegeneration in Aging
Name	Canadian Consortium on Neurodegeneration in Aging
Formation	2014
Type	Research network
Headquarters	Toronto
Region served	Canada
Leader title	Scientific Director

Canadian Consortium on Neurodegeneration in Aging is a Canadian research network established to coordinate multidisciplinary studies of neurodegenerative diseases affecting older adults. The consortium links academic institutions such as University of Toronto, McGill University, University of British Columbia, and McMaster University with clinical centres including Sunnybrook Health Sciences Centre, Montreal Neurological Institute and Hospital, and Vancouver General Hospital to accelerate translational research. It connects investigators working on disorders like Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and frontotemporal dementia and integrates expertise from institutions such as Toronto Rehabilitation Institute, Ottawa Hospital Research Institute, and Universidad de Montreal.

History

The consortium was launched following national research initiatives influenced by programs at National Institutes of Health, Canadian Institutes of Health Research, Alzheimer Society of Canada, and provincial agencies including Ontario Ministry of Health and Quebec Ministry of Health and Social Services. Early milestones involved partnerships with centres such as Baycrest Health Sciences, Sunnybrook Research Institute, St. Michael's Hospital, and Hamilton Health Sciences and were informed by international efforts like European Research Council, Wellcome Trust, Medical Research Council (United Kingdom), and NIHR. Founding meetings convened investigators from Dalhousie University, University of Calgary, Queen's University, and University of Waterloo alongside representatives from Heart and Stroke Foundation of Canada and philanthropic organizations such as The Terry Fox Foundation and Gairdner Foundation.

Organization and Governance

Governance draws on academic leadership models used at Harvard Medical School, Johns Hopkins University School of Medicine, and Imperial College London and includes advisory boards with members from Canadian Medical Association, Royal College of Physicians and Surgeons of Canada, and national patient organizations like Alzheimer Society of Canada and Parkinson Canada. The consortium's structure aligns with best practices from Hôpital Sainte-Justine, University Health Network, and Research Canada and includes ethics oversight comparable to committees at Mount Sinai Hospital (Toronto), McGill University Health Centre, and CHU Sainte-Justine. Leadership has engaged experts affiliated with Sunnybrook Health Sciences Centre, Baycrest Health Sciences, University of Ottawa Heart Institute, and Centre hospitalier universitaire de Québec to coordinate scientific strategy.

Research Programs and Initiatives

Programs encompass longitudinal cohorts, biomarker discovery, neuroimaging, and clinical trials modeled on protocols used by Alzheimer's Disease Neuroimaging Initiative, Parkinson's Progression Markers Initiative, and multicentre studies at Mayo Clinic. Core initiatives involve collaborations with laboratories at Robarts Research Institute, Hotchkiss Brain Institute, Montreal Neurological Institute and Hospital, and Rotman Research Institute to develop fluid biomarkers, genetic studies tied to datasets from Genome Canada, and imaging initiatives using platforms at Canadian Light Source, MaRS Discovery District, and Terry Fox Laboratory. Trials draw on methodologies from International Conference on Alzheimer’s and Parkinson’s Diseases and leverage networks such as Canadian Stroke Network and Canadian Critical Care Trials Group.

Collaborations and Partnerships

The consortium partners with provincial health authorities including Alberta Health Services, British Columbia Ministry of Health, and Manitoba Health, and forms research alliances with international organizations like World Health Organization, European Union Horizon 2020, National Institute for Health Research, and philanthropic entities such as Michael J. Fox Foundation. Academic partnerships include University of Saskatchewan, University of Manitoba, Université Laval, and University of Victoria, while clinical partners include Health Sciences North, Royal Victoria Hospital (Halifax), and St. Joseph's Healthcare Hamilton. Industry collaborations have involved companies analogous to Roche, Biogen, Eli Lilly and Company, and Novartis for therapeutic development and trials.

Funding and Resources

Funding streams reflect mixes used by Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council, and Genome Canada alongside provincial research funds from Ontario Research Fund, Saskatchewan Health Research Foundation, and Québec’s Fonds de recherche du Québec. Additional support has come from charitable organizations such as Canadian Cancer Society (for shared infrastructure), GlaxoSmithKline–style industry partnerships, and philanthropic gifts resembling contributions to University Health Network and Montreal Heart Institute Foundation. Resource platforms include biobanks housed at Lunenfeld-Tanenbaum Research Institute, data repositories patterned after UK Biobank, and computing resources similar to those at Compute Canada.

Impact and Outcomes

Outcomes include standardized protocols adopted by clinical centres such as Sunnybrook Health Sciences Centre and Montreal Neurological Institute and Hospital, contributions to national datasets used by Alberta Innovates, and training programs that partner with graduate programs at University of Toronto, McGill University, and University of British Columbia. The consortium’s work has informed public health discussions alongside agencies like Public Health Agency of Canada and shaped clinical practice recommendations echoing guidelines from Canadian Neurological Sciences Federation. Scholarly output has been cited in journals associated with Nature Medicine, The Lancet Neurology, JAMA Neurology, and has supported investigator-led trials comparable to those registered with ClinicalTrials.gov and overseen by institutions such as Health Canada.

Category:Neuroscience organizations in Canada